Immune testing before and after spleen removal for ITP
Part of Blood & lymphatic clinical trials.
This study checks how your immune system is doing before and after a spleen removal surgery (splenectomy) for immune thrombocytopenia (ITP). It may help doctors better understand what changes happen in the body and how to improve care for people with ITP.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 60 years old
- You have been diagnosed with immune thrombocytopenia (ITP)
- Your doctors have decided you need a spleen removal (splenectomy)
- You agree to join the study by signing consent and follow the study steps
- Your low platelet count is not from another cause (not secondary thrombocytopenic purpura)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood test antibodies to help confirm whether low platelet counts are caused by an autoimmune condition. It may help doctors better classify your type of low platelets and guide appropriate next steps.
This trial tests a medicine called romiplostim (Nplate) as a first treatment for adults newly diagnosed with ITP. It aims to see if it can safely raise platelet counts and reduce bleeding risk.
This trial studies whether “TPO” medicines (like eltrombopag or similar drugs) help people age 14 and older with primary immune thrombocytopenia (ITP) who did not respond well to first treatments. It may help raise platelet counts and reduce bleeding, especially when prior therapy hasn’t worked.
This study looks at how people with immune thrombocytopenia (ITP) are doing after having their spleen removed. By tracking your health over time, researchers hope to learn more about the long-term results of this treatment.
This study looks at children newly diagnosed with immune thrombocytopenia (ITP) or lupus (SLE) before they start treatment. Researchers want to understand how these conditions develop, which may lead to better care.
This study looks at blood and immune system patterns in adults with primary immune thrombocytopenia (ITP) who are starting their first treatment. The goal is to better understand what’s happening in ITP, which may improve how future patients are cared for.
Hear when a new Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.